Arkolith/Insider Trading/TDOC/Form 4

Divita Charles III

CHIEF EXECUTIVE OFFICER, DirectorTeladoc Health, Inc. (TDOC) · full profile →Form 4 · filed Jun 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$146K
Net Open-Market Flow
-$146K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Sell(S)19K$7.63$146K390K
Jun 1, 2026Option exercise(M)2K——367K
Jun 1, 2026Option exercise(M)42K——409K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)2K—$014K
Jun 1, 2026Option exercise(M)42K—$0296K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001347535-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML